Clinical Trial Update: Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating a dexamethasone–ifosfamide–cisplatin–etoposide regimen in natural killer/T-cell lymphoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Natural Killer T-cell Lymphoma

Drugs mentioned

• CISPLATIN (cisplatin)
• DEXAMETHASONE (Dexamethasone)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: Fudan University | Conditions: Lymphoma | Phase 2 | Status: UNKNOWN